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1. Introduction 
Chronic renal failure (CRF) is defined as a progressive decline in renal function associated 
with a reduced glomerular filtration rate. The most common causes are diabetes mellitus, 
glomerulonephritis and chronic hypertension (Proctor et al., 2004). 
The clinical signs and symptoms of renal failure are collectively termed ‘uremia’. CRF 
affects most body systems, and the clinical features are dependent upon the stage of renal 
failure and the systems involved. 
Oral manifestations of CRF and related therapies: 
a. Gingival enlargement 
Gingival enlargement secondary to drug therapy is the most commonly reported oral 
manifestation of renal disease. It can be induced by cyclosporine and/or calcium 
channel blockers (Somacarrera et al., 1994; Kennedy and Linden 2000). 
b. Oral hygiene and periodontal disease 
The oral hygiene of individuals receiving hemodialysis can be poor. Deposits of 
calculus may be increased (Epstein et al., 1980; Gavalda et al., 1999). There is no good 
evidence of an increased risk of periodontitis (Brown et al., 1989; Thorstensson et al., 
1996; Naugle et al., 1998), although premature bone loss has been reported (Locsey et 
al., 1986). Localized suppurative osteomyelitis, secondary to periodontitis, was 
observed in individuals receiving hemodialysis (Tomaselli et al., 1993). 
c. Xerostomia 
Symptoms of xerostomia can arise in many individuals receiving hemodialysis (Kho et 
al., 1999; Klassen and Krasko, 2002). Possible causes include restricted fluid intake, side-
effects of drug therapy and/or mouth breathing (Porter et al., 2004). 
d. Oral malodor/bad taste/halitosis 
Uremic patients may have an ammonia-like oral odor (Kho et al., 1999), which also 
occurs in about one third of individuals receiving hemodialysis. CRF can give rise to 
altered taste sensation, and some patients complain of an unpleasant and/or metallic 
taste or a sensation of an enlarged tongue (Kho et al., 1999). 
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e. Mucosal lesions 
A wide range of oral mucosal lesions, particularly white patches and/or ulceration, 
have been described in individuals receiving dialysis and allografts (Proctor et al., 
2004).  
f. Oral malignancy 
Kaposi’s sarcoma (KS) can occur in the mouths of immunosuppresed renal transplant 
recipients (Farge, 1993). Any increased risk of oral malignancy in CRF probably reflects 
the effects of iatrogenic immunosupression, which increases the risk of virally-
associated tumors, such as KS or non-Hodgkin’s lymphoma (Proctor et al., 2004).  
g. Oral infections 
Candidosis, angular cheilitis has been described in up to 4% of hemodialysis and renal 
allograft recipients (King et al., 1994; Klassen and Krasko, 2002). Other oral candidal 
lesions—such as pseudomembranous (1.9%), erythematous (3.8%), and chronic atrophic 
candidosis (3.8%)—have been reported in allograft recipients (King et al., 1994).  
Viral infection, prior to the availability of appropriate anti-viral drugs (e.g., acyclovir, 
gancyclovir, and valacyclovir), about 50% of renal allograft recipients, who were 
seropositive for herpes simplex, experienced recurrent, severe, and prolonged HSV 
infections (Armstrong et al., 1976). However, in recent years, the use of effective anti-
herpetic regimes has significantly reduced the frequency of such infection (Kletzmayr et 
al., 2000; Squifflet and Legendre 2002). 
h. Dental anomalies 
Delayed eruption of permanent teeth has been reported in children with CRF (Wolff et 
al., 1985; Jaffe et al., 1990). Enamel hypoplasia of the primary and permanent teeth (Kho 
et al., 1999; Koch et al., 1999; Al Nowaiser et al., 2003) with or without brown 
discoloration can also occur (Wolff et al., 1985). 
i. Bone lesions 
A wide range of bone anomalies can arise in CRF. These reflect a variety of defects of 
calcium metabolism including, loss of hydroxylation of 1-hydroxycholecalciferol to 
active vitamin D (1,25-dihydroxycholecalciferol), decreased hydrogen ion excretion 
(and resultant acidosis); hyperphosphatemia, hypocalcemia and resultant secondary 
hyperparathyroidism and interference with phosphate metabolism by dialysis (Nadimi 
et al., 1993). 
Orofacial features of renal osteodystrophy due to hyperparathyroidism include bone 
demineralization, decreased trabeculation, decreased thickness of cortical bone, 
ground-glass appearance of bone, metastatic soft-tissue calcifications, radiolucent 
fibrocystic lesions, radiolucent giant cell lesions, lytic areas of bone, jaw fracture (due to 
trauma or during surgery) and abnormal bone healing after extraction. Orofacial 
features of renal osteodystrophy related to tooth and periodontium include delayed 
eruption, enamel hypoplasia, loss of the lamina dura, widening of the periodontal 
ligament, severe periodontal destruction, tooth mobility, drifting, pulp calcification and 
pulp narrowing (Damm et al., 1997; Okada et al., 2000; Klassen and Krasko, 2002). 
2. The relationships among osteoporosis, renal function and periodontal 
disease  
Osteoporosis is the most common metabolic bone disease among the elderly, and the 
incidence of osteoporotic fractures obviously increases with age (Honig, 2010). In addition, 
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elderly people often experience periodontal destruction. Because bone loss is a common 
feature of periodontitis and osteoporosis, both diseases may share some common etiologic 
factors (Offenbacher, 1996). The final expression of periodontitis is governed by complex 
interactions among host, microbial and environmental factors occurring within an intricate 
cellular mosaic (Offenbacher, 1996). 
In addition, CRF is associated with marked disturbances of bone structure and metabolism, 
and there is a slowly progressive loss of renal function over months or years (Ruggeneti, 
1998). A significant decrease in bone mineral density after transplantation is a serious 
finding (Huang & Sprague, 2009). It is well known that impaired renal function increases 
osteoclast activity leading to bone turnover, and this may influence bone metabolic 
parameters (Couttenye et al., 1999; Cirillo et al., 1998). There is a growing body of evidence 
indicating that impaired renal function is associated with disrupted regulation of vitamin D 
(Rix et al., 1999; Hamdy et al., 1995). Whereas some systemic factors that contribute to loss of 
bone mass and periodontal progression have been identified, we hypothesized that renal 
function is associated with bone metabolism, and thus is also associated with periodontal 
disease. To test this hypothesis, it is essential to evaluate the relationships among bone 
turnover, renal function and periodontal disease. 
We initiated a longitudinal interdisciplinary study on aging (the Niigata Study) in 1998 to 
examine the many links between oral health and general health and well being. In the 
present report, we reviewed the relationship between bone metabolism and periodontal 
disease, taking renal function into consideration, in elderly Japanese subjects from the 
Niigata Study. 
3. Principal findings from the Niigata Study 
3.1 Outline of the Niigata Study 
According to a registry of residents, questionnaires were sent to all 70-year-olds among the 
4,542 inhabitants of Niigata City in Japan. Participants were informed of the purpose of the 
survey, and the overall response rate was 81.4%. After dividing the residents into groups of 
males and females, 600 individuals (the screened population) were randomly selected in 
order to have approximately the same number of male and female participants in the study. 
Follow-up surveys were carried out every year in June from1998 to 2008 (11 times in 10 
years), using the same methods that were used at baseline. All subjects were Japanese and 
did not require special care for their daily activities. Since age influences bone metabolism, 
renal function and periodontal disease, subjects were restricted to 70 years old at baseline 
(Ando et al., 2000). 
3.2 Osteoporosis and periodontal disease 
In addition to a strict age requirement, other study inclusion criteria included the following: 
blood sugar < 140 mg/dL with no history of diabetes, more than 20 teeth remaining, non-
smokers, and no history of medication use for osteoporosis. There were 184 subjects among 
the screened population that met all the inclusion criteria. 
We utilized data on bone mineral density (BMD) of the heel, which we measured using an 
ultrasound bone densitometer (Fig. 1, Achilles Bone DensitometerTM, Luner Corporation,  
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Fig. 1. Outline of the analysis between Osteoporosis and periodontal progression. 
AAL: Additional attachment loss. 
USA) (Lunar Corporation, 1991). Ultrasound densitometry enables the measurement of the 
physical properties of bone, specifically BMD. The ultrasound measurement contains two 
criteria, the velocity (speed of sound, SOS) and frequency attenuation (broadband 
ultrasound attenuation, BUA) of a sound wave as it travels through a bone. Stiffness is a 
clinical index combining SOS and BUA, and is calculated by the following formula: (BUA − 
50) × 0.67 + (SOS − 1380) × 0.28. 
Stiffness is indicated in the bone densitometer monitoring device as the percentage of the 
value for a normal younger population. Osteopenia was defined as a stiffness that was  
85% for males and  69% for females. Follow-up clinical surveys were done by measuring 
the clinical attachment level after 3 years. Clinical attachment level is the amount of space 
between attached periodontal tissues and a fixed point, usually the cementoenamel junction. 
A measurement used to assess the stability of attachment as part of a periodontal 
maintenance program (Fig. 2). There were 179 subjects included in the final analysis, and all 
of these subjects participated in both the baseline and the follow-up examinations. 
We measured the number of progressive sites that had  3 mm of additional attachment loss 
over 3 years (Fig. 2). After dividing the subjects into an osteopenia group (OG) and a no-
osteopenia group (NOG), we evaluated the number of progressive sites that had  3 mm of 
additional attachment loss over 3 years by two-way analysis of variance (ANOVA). 
The respective mean number of progressive sites for the OG and NOG were 4.75.5 and 
3.33.0 in females, and 6.99.4 and 3.42.8 in males. The difference in the mean number of 
progressive sites between the OG and NOG was statistically significant by ANOVA after 
controlling for gender (Fig. 3, p = 0.043) (Yoshihara et al., 2004). 
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Fig. 2. Clinical attachment level and periodontal disease progression. 
A, B = Clinical attachment level 
B-A = Additional attachment loss 
 
Fig. 3. Relationship between number of progressive sites with 3mm additional attachment 
loss and stiffness by gender. 
The number of subjects: stiffness 69 (n=74) and >69 (n=19) for female, 85 (n=65) and >85 
(n=22) for male. 
OG: Osteopenia group, NOG: No-osteopenia group. 
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3.3 Bone metabolism and periodontal disease 
A total of 398 subjects who turned 70 in 1998 had annual dental examinations. We selected 
148 of these 398 subjects (79 males and 69 females) for participation in the study because 
they had one or more teeth, were not taking any medicine or supplements for bone 
disorders (tamoxifen, anabolic steroids, bisphosphonate, or estrogen), and did not have a 
diagnosis of fracture based on an X-ray assessment by a physician. The subject’s blood was 
taken in the morning of the dental examination. Urine was collected over 24 hours (07:00 to 
07:00 AM the day after the dental examination). During the day that urine was collected, 
usual food and fluid intake were ingested. Biochemical parameters of bone turnover were 
measured, including urinary deoxypyridinoline (U-DPD) (nM/nM*Cr) as a bone resorption 
marker, and serum osteocalcine (S-OC) (ng/mL) and serum bone alkaline phosphatase (S-
BAP) (U/L) as bone formation markers. U-DPD data were corrected by the urinary 
creatinine concentration measured by a standard colorimetric method. 
We categorized subjects by tertiles according to the percentage of sites with 6 mm clinical 
attachment level (6+ mm CAL). S-OC, S-BAP, and U-DPD were evaluated by analysis of 
covariance (ANCOVA) adjusted for smoking habit (0: none, 1: past or current). Differences 
in the distribution of bone turnover markers according to the percentage of sites with 6+ 
mm CAL per person are shown in Table 1. S-OC was significantly lower in the third tertile 
than in the first and second tertiles after adjusting for smoking habit (males: p = 0.007, 
females: p = 0.042, ANCOVA) (Yoshihara et al., 2009). 
 
  % of sites with 6mm attachment level   
  Males   Females   
  1st 2nd 3rd p value* 1st 2nd 3rd p value* 
Serum osteocalcin 
(ng/ml) 
8.5 ± 4.5 6.8 ± 2.7 5.7 ± 1.8 0.007 9.9 ±2.8 9.3 ± 2.4 9.1 ± 3.5 0.042 
Serum bone alkaline 
phosphatase (U/L) 
22.2 ± 5.9 23.3 ± 7.4 21.1 ± 6.2 0.212 29.3 ± 10.8 28.9 ± 8.1 27.4 ± 11.2 0.752 
Urinary 
deoxypyridinoline 
(nM/nM*Cr) 
4.8 ± 1.0 4.4 ± 1.2 4.0 ± 1.0 0.055 6.6 ± 1.4 6.8 ± 1.4 6.3 ± 1.7 0.664 
* ANOCOVA adjusted for smoking habits. 
Table 1. Relationship between % of sites with ≥ 6mm attachment level and bone metabolism 
markers controlling for confounding factors by multiple regression analysis. 
3.4 Renal function and periodontal disease 
We randomly selected 145 subjects among 398 healthy elderly subjects. All subjects were 
aged 77 years at the time of the renal function study in 2005. We evaluated the relationship 
between bone turnover markers and periodontal disease, taking renal function into 
consideration. Correlations among renal function and bone metabolism markers for 
periodontal disease, including the number of remaining teeth and smoking habit, were 
evaluated using multiple regression analysis. 
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To evaluate the relationship between periodontal disease and renal function markers 
(volume of urine per 24 hours [mL/day], creatinine clearance per 24 hours [L/day]) or bone 
metabolism markers (U-DPD [nM/nM*Cr] and S-OC [ng/mL]), multiple linear regression 
analysis was performed. For the final model, the confounding independent variables that 
had p-values less than 0.05 according to the statistical association with the percentage of 
sites with 6+ mm CAL by Pearson correlation coefficients, ANOVA, or chi-square test, were 
selected. Results of multiple linear regression analysis between the percentage of sites with 
6+ mm CAL and renal function markers after controlling for confounding factors are shown 
in Table 2. Creatinine clearance for 24 hours was positively associated with the percentage of 
sites with 6+mm CAL (sta. coef. = 0.26, p = 0.015). Furthermore, S-OC showed a negatively 
independent association with the percentage of sites with 6+vmm CAL after adjustment for 
the confounding factors (sta. coef. = -0.27, p = 0.006, Table 3) (Yoshihara et al, 2007). 
  Dependent variable 
  % of sites with ≥6mm attachment level 
Independent variables Sta. Coef (β).* p value 
Number of remaining teeth -0.46  <0.001 
Creatinine clearance for 24 h (L/day)† 0.26  0.015  
Volume of urine for 24 h (ml/day) 0.01  0.956  
Smoking habit 0.08  0.500  
Gender -0.17  0.121  
Use of interdental brushes or dental floss -0.01  0.893  
Constant   0.074  
†Creatinine (g/day) in urine per 24h/creatinine (g/L) in serum. 
* Standardized coefficient. 
Table 2. Relationship between % of sites with ≥6mm attachment level and renal function 
markers controlling for confounding factors by multiple regression analysis. 
  Dependent variable 
  % of sites with ≥6mm attachment level 
Independent variables Sta. Coef (β).* p value 
Number of remaining teeth -0.47  <0.001 
Serum osteocalcin (ng/ml) -0.27  0.006  
Urinary deoxypyridinoline (nM/nM*Cr) -0.04  0.688  
Smoking habit -0.10  0.406  
Gender 0.10  0.481  
Use of interdental brushes or dental floss -0.01  0.861  
Constant   <0.001 
* Standardized coefficient. 
Table 3. Relationship between % of sites with ≥ 6mm attachment level and bone metabolism 
markers controlling for confounding factors by multiple regression analysis. 
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The results showed that the subjects in the OG had a higher number of progressive sites for 
additional attachment loss than the subjects in the NOG. This three-year longitudinal study 
clearly demonstrated that BMD is a risk factor for periodontal disease progression in an 
elderly population. In addition, according to our findings on linkage with BMD, there are 
some systemic factors that contribute to both loss of bone mass and periodontal disease 
progression (Kshirsagar, 2005). Systemic factors of bone remodeling may also modify the 
local tissue response to periodontal disease. The BMD of the mandible is affected by the 
mineral status of the skeleton and also by diseases that cause generalized bone loss 
(Davidovich, 2005). The mouth and face are highly accessible parts of the body, and reflect 
changes that occur internally. For the clinician, the mouth and face provide physical signs 
and symptoms of local and generalized disease. During routine oral examinations, 
periodontal disease including maxillary/mandibular general bone loss may be diagnostic of 
early osteoporotic changes in the skeleton. Some systemic factors of bone remodeling also 
modify the local tissue response to periodontal disease. 
Osteoporosis and low renal function contribute to loss of bone mass. We were able to 
identify a weak but clear relationship between CAL and S-OC. There was a significant 
association between CAL and 24-hour creatinine clearance, which is a renal function marker. 
These findings suggest that S-OC is a valid marker of bone turnover when evaluating 
periodontal disease. It has been assumed that S-OC is associated with not only bone 
turnover but also low renal function. Periodontal conditions, including bone metabolism, 
may be affected by low renal function. The systemic bone metabolism, which might be 
affected by low renal function, is associated with periodontal disease. 
4. Association between chronic renal failure and periodontal disease 
Based on several studies, CRF and periodontal disease can have reciprocal effects (Fig. 3). 
CRF and renal therapy can greatly influence the dental management of renal patient. 
Moreover, chronic adult periodontitis can contribute to the overall systematic inflammatory 
burden and may therefore influence the management of the end-stage renal disease (ESRD) 
patient on hemodialysis maintenance therapy (Craig, 2008). 
4.1 Possible association of chronic renal failure with periodontal disease 
CRF can cause several changes that influence oral conditions such as decreased salivary 
flow rate, increase salivary urea level and calculus accumulation (Torres et al., 2010). CRF 
may have an effect on the periodontal status of an individual through several possible 
mechanisms. 
a. A major clinical consequence of CRF is uremic syndrome (uremia). This condition 
leads to an immune dysfunction possibly caused by defects in lymphocyte and 
monocyte function, which in turn may increase the rate of gingival inflammation 
(Craig, 2008). 
b. Several studies have found an increasing level of plaque formation, calculus, gingival 
inflammation and also decreasing saliva excretion, which can be considered together as 
reduced oral hygiene (Yoshihara et al., 2007). The intense psychological and time 
demands that are associated with hemodialysis in patients with ESRD may account for 
reduced oral hygiene (Craig, 2008). 
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Fig. 4. The mechanism between low renal function and periodontal disease. 
c. CRF has an important effect on vitamin D metabolism (Yoshihara et al., 2007). Since 
vitamin D is metabolized in the liver and kidney, the presence of CRF will 
automatically disturb vitamin D metabolism. Vitamin D is metabolized by kidney to 
its active metabolite, 1,25-dihydroxyvitamin D3. This substance subsequently 
interacts with vitamin D nuclear receptor in the intestine, bone and kidney. The 
functions of this substance are to regulate bone metabolism, immune response and 
also cell proliferation and differentiation. Regarding bone metabolism, vitamin D 
controls the availability of calcium phosphate by regulating the excretions of 
hormones such as the parathyroid hormone (PTH) (Souza et al., 2007). CRF may 
disrupt the regulation of PTH which may leads to hyperparathyroidism condition 
and increased rate of bone disease (Yoshihara et al., 2007). Vitamin D also contributes 
in the synthesis of bone matrix proteins such as type-I collagen, alkaline phosphatase, 
osteocalcin and osteopontin (Souza et al., 2007). Osteocalcin may exist in the 
circulating blood and undergo local accumulation in some parts of the body. 
Osteocalcin has been postulated to have a role in both bone resorption and 
mineralization and is currently considered the most specific marker of osteoblast 
function. The serum level of this protein is considered to be a marker of bone 
formation. Serum osteocalcin is presently considered a valid marker of bone turnover 
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when resorption and formation are coupled and a specific marker of bone formation 
when formation and resorption are uncoupled (Bullon et al., 2005). Osteocalcin has 
also been found in the gingival crevicular fluid (GCF). Several studies found an 
increased level of serum osteocalcin in subjects with CRF. Moreover, the level of GCF 
osteocalcin was found to be significantly associated with periodontal disease, since 
there was an association with pocket depth, clinical attachment level and bleeding on 
probing (Bullon et al., 2005). Therefore, it might be reasonable to explain an effect of 
CRF on periodontal disease by its effect on bone metabolism (especially alveolar 
bone) which is specifically marked by the level of serum osteocalcin and/or GCF 
osteocalcin. 
4.2 Possible association of periodontal disease with chronic renal failure 
Periodontal disease may have an effect on CRF and also the treatment of CRF. Periodontal 
disease may have an effect on CRF through several possible mechanisms. 
a. Moderate to severe periodontal disease may increase the serum level of C-reactive 
protein (CRP). CRP is an acute phase protein and systemic marker of inflammation 
which is also a major risk predictor for cardiac disorder and all other mortality cause of 
CRF persons (Craig, 2008). Several studies have reported periodontal disease to be 
associated with elevated CRP as well as other serum components of the acute phase 
response including decreased high density lipoprotein cholesterol, low density 
lipoprotein cholesterol, blood glucose and decreased peripheral blood neutrophil 
function and count (Muntner et al., 2000). Since all these factors are also risk factors for 
CRF, it might be justifiable to assume that periodontal disease may be considered as a 
predisposing factor and/or marker of CRF. Moreover, periodontal disease in a person 
with CRF has a strong tendency to increase the possibility of the complication of 
coronary atherosclerosis.  
b. Several reports found that periodontitis may also contribute to the systemic 
inflammatory burden in ESRD. The level of IgG antibody particularly to 
Porphyromonas gingivalis correlated with elevated serum CRP (Muntner et al., 2000). 
Therefore, it is also important to consider an effective periodontal therapy in order to 
reduce the level of serum CRP which might eventually decrease the inflammatory 
burden of ESRD or CRF.  
On the other hand, there are also some studies which failed to find the type of correlations 
mentioned above (Kitsou et al., 2000; Marakoglu et al., 2003; Duran et al., 2004; Bots et al., 
2006). It is acknowledged that differences in research design, measurement methods 
instruments used, and other factors may have resulted in different findings. Therefore, it  
is still relevant and reasonable to execute further research using a more sophisticated  
and well-designed method to elucidate the relationship between CRF and periodontal 
disease. 
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